High-profile coalition is taking aim at food insecurity
A group of prominent corporate, not-for-profit and government organizations is launching perhaps the most ambitious food-relief and sustainability program here in years.
A group of prominent corporate, not-for-profit and government organizations is launching perhaps the most ambitious food-relief and sustainability program here in years.
The grants cover groups in 57 counties, with more than a third of the 297 organizations based in Indianapolis.
The situation remains murky, as several drugmakers and research institutions are scrambling to develop a vaccine, but none have yet won approval from the Food and Drug Administration to distribute the drug.
Eli Lilly and Co. said Wednesday that the U.S. government will accept 300,000 vials of the drug, called bamlanivimab, if the Food and Drug Administration grants emergency authorization for its use.
Candy Gee is responsible for advancing the Roche Diagnostics’ focus on diverse talent acquisition and development, building external partnerships, developing sustainable diversity and inclusion strategies and processes, and employee education.
Sarena Lin, who joined Elanco Animal Health three years ago, leads the company’s ongoing separation from former parent Eli Lilly and Co. and is simultaneously leading the integration into the company of Bayer Animal Health, which Elanco acquired this year for $7.6 billion.
Patricia A. Martin is head of BioCrossroads, the group that promotes Indiana’s life sciences industry, a pillar of the state’s economy,
The projects include a two-building development in Broad Ripple that would serve as the headquarters for the staffing firm Eight Eleven Group.
Although federal officials pulled the plug on a trial testing a Lilly antibody drug for people hospitalized with COVID-19, other studies for the therapy are continuing on populations that could become big markets.
The discontinuation of the study, along with the release of third-quarter earnings that fell short of analysts’ expectations, caused Lilly shares to fall 3.5% in premarket trading Tuesday.
Even as he’s worked to lead the state through the coronavirus pandemic, Gov. Eric Holcomb has managed to raise millions of dollars for his reelection campaign.
A startup that’s planning to launch a $60 million drug-manufacturing plant sees big growth in contract manufacturing.
The joint statement by Indiana University Health, Community Health Network and Eskenazi Health is the latest pledge by Indianapolis-area business groups to address racial inequities.
What leads to a strong and sustainable business? We’d like to suggest three aspects leaders need to pay attention to: values, relationships and balance.
A panel of experts spoke at IBJ’s Life Sciences Power Breakfast, which took place virtually Oct. 9, talked about venture capital in the life sciences sector. These are some excerpts.
We urge more companies to make similar commitments, whether they do so publicly by participating in the equity pledge or privately with accountability from within their own organizations.
The Indy Racial Equity Pledge, launched Oct. 8, details what nine Indianapolis-area employers plan to do to improve racial equity within their organizations, the Indianapolis area, and beyond.
Eli Lilly and Co. already has begun manufacturing the drug and expects to have 1 million doses by December, the executive in charge of COVID-19 research said Friday at IBJ’s Life Sciences Power Breakfast.
Experimental antibody drugs like the one President Trump was given and the one Eli Lilly is developing are among the most promising therapies being tested for treating and preventing coronavirus infections. Here’s how they work.
The pledge “to hold their organizations accountable for driving measurable progress in advancing racial equity” was signed by numerous major employers and organizations in central Indiana.